ArticleRSC advances2026
Hydrothermally synthesized cobalt selenide graphene nanocomposite as a sensitive probe for electrochemical profiling of dopamine and uric acid.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrochemical sensing is an affordable and efficient method for detecting a wide range of biologically, medically, and environmentally important substances. Carbon-based materials, such as graphene and carbon nanotubes, are commonly employed in the fabrication of electrochemical sensors due to their unique structures and advantageous properties including high electrocatalytic activity, minimal surface fouling, low cost, biocompatibility, and efficient electron transfer kinetics. This study proposes the hydrothermal synthesis of graphene based cobalt selenide (CoSe@GO) nanocomposites for electrochemical sensing of uric acid and dopamine. The as-fabricated electrode's structure and morphology were examined using scanning electron microscopy (SEM) coupled with energy-dispersive X-ray spectroscopy (EDS). X-rays diffraction (XRD) was employed to examine the crystalline structure and phase composition of the microelectrode material. While electrochemical performance was evaluated using various electrochemical methods, including cyclic voltammetry and chronoamperometry. The fabricated CoSe-GO@GCE sensor provides a good linear range of up to 1.6 mM and 2.0 mM with a low detection limit of 1.5 mM and 0.03 mM for dopamine and uric acid, respectively. By developing these advanced nanocomposites, this research seeks to enhance sensitivity, selectivity, and detection limits for uric acid and dopamine, contributing to improved biomedical diagnostics and monitoring.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.